MoneyWorks4Me

Syschem India informs about clarification

10 Aug 2026 Evaluate
Syschem India has informed that due to an inadvertent typographical error, “Q2 (Quarter-2)” has been mentioned at certain places in the Investor Presentation, whereas the same should have been mentioned as ‘Ql (Quarter-1)’, pertaining to the First Quarter of Financial Year 2026-27. Accordingly, wherever ‘Q2 (Quarter-2)’ appears in the said Investor Presentation, the same shall be read and understood as ‘Q1 (Quarter-1)’. Further clarified that the aforesaid error is purely typographical in nature and does not have any impact on the financial figures, operational information, financial results, or any other disclosures contained in the Investor Presentation. The Company regrets the inadvertent typographical error and is taking necessary steps to upload the corrected Investor Presentation on the Stock Exchange portal. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..